glp 1 agonist anesthesia ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New Study Recommends Stopping GLP-1
Description
According to the Centers for Disease Control and Prevention (CDC), over 40% of adults are currently living with obesity , a figure projected to reach 50% by 2030
doi: 10.1111/j.1523-1755.2004.00790.x [DOI] [PubMed] [Google Scholar] 25.Maalouf NM, Langston JP, Van Ness PC, Moe OW, Sakhaee K
Miller L
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects
Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia
